Evidence map›Paper›PMID 24848971›Full record

ArticleAngewandte Chemie (International ed. in English)2014

Synthetic disialyl hexasaccharides protect neonatal rats from necrotizing enterocolitis.

Hai Yu, Kam Lau, Vireak Thon, Chloe A Autran, Evelyn Jantscher-Krenn, Mengyang Xue, Yanhong Li, Go Sugiarto, Jingyao Qu, Shengmao Mu and 3 more

Open access · greenAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Synthesis as an Expanding Resource in Human Milk Science.Journal of the American Chemical Society · 2021
    Review
  11. The need to study human milk as a biological system.The American journal of clinical nutrition · 2021
    Article
  12. Article
  13. Synthetic Carbohydrate Chemistry and Translational Medicine.The Journal of organic chemistry · 2020
    Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Redox-Controlled Site-Specific α2-6-Sialylation.Journal of the American Chemical Society · 2019
    Article
  20. Oligosaccharide Synthesis and Translational Innovation.Journal of the American Chemical Society · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Hai YuDepartment of Chemistry, University of California-Davis, One Shields Avenue, Davis, CA 95616 (USA).
Kam Lau
Vireak Thon
Chloe A Autran
Evelyn Jantscher-Krenn
Mengyang Xue
Yanhong Li
Go Sugiarto
Jingyao Qu
Shengmao Mu
Li Ding
Lars Bode
Xi Chen
University of California, Davis · USUniversity of California, San Diego · USGeorgia State University · US

Funding

Oligosaccharides as antimicrobials and prebioticsR01HD065122 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEN, XI · 2010 to 2013
$1.8M
Fusing Glycobiology and Nutritional Sciences to Prevent Necrotizing EnterocolitisR00DK078668 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BODE, LARS · 2009 to 2011
$747k
NICHD NIH HHS R01 HD065122NICHD NIH HHS R01HD065122NIDDK NIH HHS R00 DK078668PHS HHS R00K078668
6 · The paper itself

Abstract

Two novel synthetic α2-6-linked disialyl hexasaccharides, disialyllacto-N-neotetraose (DSLNnT) and α2-6-linked disialyllacto-N-tetraose (DS'LNT), were readily obtained by highly efficient one-pot multienzyme (OPME) reactions. The sequential OPME systems described herein allowed the use of an inexpensive disaccharide and simple monosaccharides to synthesize the desired complex oligosaccharides with high efficiency and selectivity. DSLNnT and DS'LNT were shown to protect neonatal rats from necrotizing enterocolitis (NEC) and are good therapeutic candidates for preclinical experiments and clinical application in treating NEC in preterm infants.

Indexed as

AnimalsBifidobacteriumDrug Evaluation, PreclinicalEnterocolitis, NecrotizingMultienzyme ComplexesOligosaccharidesProtective AgentsRatsdisialyllacto-N-tetraoseMultienzyme ComplexesOligosaccharidesProtective Agentsdisialyl glycansenzymatic synthesisenzymesnecrotizing enterocolitisoligosaccharides

Identifiers

PMID24848971
PMCPMC4147952
OpenAlexW2160124838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.